In outlining priorities, Waxman targets DTC ban in select cases
This article was originally published in Scrip
Executive Summary
California congressman Henry Waxman, who will soon take over the House Energy and Commerce Committee, replacing Representative John Dingell as the leader of a committee with broad power over healthcare and FDA affairs, has begun to provide hints as to what his priorities might be. Mr Waxman won the power struggle last month (Scrip Online, November 24th, 2008).